| Filter Options | ||||||
|---|---|---|---|---|---|---|
|
Public title |
Verify status |
Pay status |
||||
|
Study ailment |
Study type |
Study phase |
||||
|
Applicant |
Study leader |
Primary sponsor |
||||
|
Countries of recruitment and research settings |
|
|||||
| More Options | ||||||
| Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
|---|---|---|---|---|---|---|---|
| YXLL-KY-2025(182) |
Observational Study on Clinical Manifestations, Biomarkers, and Quality of Life in Narcolepsy The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital) |
|
Diagnostic Accuracy Test |
|
2026-06-04 | 298 | Patient list |
| YXLL-KY-2025(182) |
Observational Study on Clinical Manifestations, Biomarkers, and Quality of Life in Narcolepsy The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital) |
|
|
|
2026-06-04 | 260 | Patient list |
| ChiCTR2500104539 |
Eye Hospital of Shandong First Medical University |
Corneal endothelial decompensation |
Therapy Study |
|
2025-06-27 | 667 | Patient list |
| ChiCTR2500104061 |
The Second Hospital of Shandong University |
|
Diagnostic Accuracy Test |
Post-market |
2025-06-25 | 670 | Patient list |
| ChiCTR2500095616 |
Shandong Eye Hospital |
|
Therapy Study |
|
2025-06-24 | 858 | Patient list |
| ChiCTR2500104523 |
Zibo First Hospital |
|
Prognostic Study |
|
2025-06-24 | 518 | Patient list |
| 248709 |
Affiliated Hospital of Qingdao University |
|
Therapy Study |
Premarket |
2024-11-23 | 930 | Patient list |
| ChiCTR2400083577 |
The Second Hospital of Shandong University |
RIF during FET cycles |
Therapy Study |
Post-market |
2024-11-05 | 862 | Patient list |
| 暂无 |
The Affiliated Hospital of Qingdao University |
Coronary atherosclerotic heart disease |
Therapy Study |
Post-market |
2024-10-29 | 783 | Patient list |
| NO |
A survey on perioperative antibiotic use for minimally invasive coronary artery bypass grafting Dong'e Peoples Hospital |
coronary artery bypass grafting |
Therapy Study |
Post-market |
2024-09-09 | 909 | Patient list |